These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 9548907)
1. Inclusion complexation of propofol with 2-hydroxypropyl-beta-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. trapani@ippo.uniba.it. Trapani G; Latrofa A; Franco M; Lopedota A; Sanna E; Liso G J Pharm Sci; 1998 Apr; 87(4):514-8. PubMed ID: 9548907 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of new propofol aqueous solutions for intravenous anesthesia. Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952 [TBL] [Abstract][Full Text] [Related]
3. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat. Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex. Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the complexation between methylprednisolone and different cyclodextrins in solution by 1H-NMR and molecular modeling studies. Thi TD; Nauwelaerts K; Froeyen M; Baudemprez L; Van Speybroeck M; Augustijns P; Annaert P; Martens J; Van Humbeeck J; Van den Mooter G J Pharm Sci; 2010 Sep; 99(9):3863-73. PubMed ID: 20665846 [TBL] [Abstract][Full Text] [Related]
6. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin. Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071 [TBL] [Abstract][Full Text] [Related]
7. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation. Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474 [TBL] [Abstract][Full Text] [Related]
8. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins. Liu B; Li W; Nguyen TA; Zhao J Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. Brewster ME; Anderson WR; Loftsson T; Huang MJ; Bodor N; Pop E J Pharm Sci; 1995 Oct; 84(10):1154-9. PubMed ID: 8801327 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
11. Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes. Veiga FJ; Fernandes CM; Carvalho RA; Geraldes CF Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1251-6. PubMed ID: 11605649 [TBL] [Abstract][Full Text] [Related]
12. Preparation and central action of propofol/hydroxypropyl-beta-cyclodextrin complexes in rabbits. Viernstein H; Stumpf C; Spiegl P; Reiter S Arzneimittelforschung; 1993 Aug; 43(8):818-21. PubMed ID: 8216434 [TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin. Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462 [TBL] [Abstract][Full Text] [Related]
14. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use. Holvoet C; Vander Heyden Y; Plaizier-Vercammen J Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630 [TBL] [Abstract][Full Text] [Related]
15. The effect of a cyclodextrin vehicle on the cardiovascular profile of propofol in rats. Bielen SJ; Lysko GS; Gough WB Anesth Analg; 1996 May; 82(5):920-4. PubMed ID: 8610899 [TBL] [Abstract][Full Text] [Related]
16. Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis. Omari MM; Badwan AA; Zughul MB; Eric J; Davies D Drug Dev Ind Pharm; 2007 Nov; 33(11):1205-15. PubMed ID: 18058317 [TBL] [Abstract][Full Text] [Related]
17. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity. Matsuda H; Ito K; Sato Y; Yoshizawa D; Tanaka M; Taki A; Sumiyoshi H; Utsuki T; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1448-52. PubMed ID: 8403092 [TBL] [Abstract][Full Text] [Related]
18. Interaction of trimeprazine with cyclodextrins in aqueous solution. Lutka A; Koziara J Acta Pol Pharm; 2000; 57(5):369-74. PubMed ID: 11126028 [TBL] [Abstract][Full Text] [Related]
19. Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity. Wang F; Yang B; Zhao Y; Liao X; Gao C; Jiang R; Han B; Yang J; Liu M; Zhou R J Biomater Sci Polym Ed; 2014; 25(6):594-607. PubMed ID: 24555409 [TBL] [Abstract][Full Text] [Related]
20. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin. Hu L; Zhang H; Song W; Gu D; Hu Q Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]